Beyond Pain Relief: Can Spinal Cord Stimulation Restore Sensation in Diabetic Neuropathy?

For people with painful diabetic neuropathy (PDN), treatment has traditionally focused on controlling burning, stabbing, and shooting pain. However, emerging research on spinal cord stimulation for diabetic neuropathy raises a more intriguing question: Could neuromodulation also improve sensation?

Results from the SENZA-PDN clinical trial suggest that some patients receiving high-frequency 10 kHz spinal cord stimulation (SCS) experienced measurable neurological and sensory improvements. Importantly, though, better sensation is not the same as repairing damaged peripheral nerves. Understanding that distinction is essential when discussing what this treatment may offer patients.

Table of Contents

• Why sensation matters in diabetic neuropathy
• What the SENZA-PDN research found
• Does improved sensation mean nerve regeneration?
• What the findings could mean for patient care
• Conclusion
• Frequently asked questions

Why Sensory Loss Matters in Diabetic Neuropathy

Diabetic peripheral neuropathy can produce two seemingly opposite problems. Some patients experience severe pain and hypersensitivity, while others gradually lose their ability to feel pressure, temperature, or injuries. In fact, both problems may occur in the same person.

Loss of protective sensation is particularly concerning because pain normally acts as the body’s warning system. Without that warning, a patient may develop a blister, cut, or pressure injury without noticing it.

The American Diabetes Association notes that diabetic nerve damage can reduce the ability to feel pain, heat, and cold. Consequently, unnoticed injuries can progress to ulcers and infections. Regular foot examinations and daily self-checks therefore remain essential for people with neuropathy.

This makes the sensory findings from recent diabetic neuropathy neuromodulation research especially interesting. If treatment influences sensation as well as pain, its clinical effects could potentially extend beyond conventional symptom control.

However, that possibility requires careful interpretation.

What Spinal Cord Stimulation Research Has Found

The SENZA-PDN trial evaluated 10 kHz spinal cord stimulation in people with refractory painful diabetic neuropathy. In the randomized study, 216 participants initially received either conventional medical management alone or 10 kHz SCS plus conventional medical management. Participants with inadequate relief could cross over after six months.

At 24 months, researchers reported substantial and durable improvements among patients receiving stimulation. Mean pain reduction from baseline was 79.9%, while 90.1% of participants experienced at least 50% pain relief. Improvements in sleep and health-related quality of life were also reported. The 24-month SENZA-PDN results provide further details on these outcomes.

Perhaps more surprising was the neurological finding. At 24 months, 65.7% of participants demonstrated what investigators classified as clinically meaningful neurological improvement. Researchers evaluated sensory, reflex, and motor function as part of those assessments.

A separate analysis focused specifically on protective sensation in the feet. Researchers used 10-g monofilament testing at multiple locations on each foot. Participants receiving 10 kHz spinal cord stimulation had more sensate locations than patients receiving conventional medical management alone and compared with their own preimplantation measurements. The protective sensation analysis offers a closer look at these findings.

That result matters because monofilament testing is commonly used clinically to identify loss of protective sensation. Therefore, the findings raise the possibility that neuromodulation for diabetic nerve pain may influence more than pain perception alone.

Still, the results need context. The trial involved people with painful, refractory diabetic neuropathy who met specific eligibility criteria. Therefore, its findings should not automatically be generalized to every person with diabetic neuropathy.

Does Better Sensation Mean Diabetic Nerve Damage Is Reversing?

This is where the distinction between clinical improvement and biological repair becomes critical.

The results do not establish that spinal cord stimulation for diabetic neuropathy regenerates peripheral nerves or reverses the underlying disease process. Instead, they show that neurological examinations and measures of sensation improved in many treated participants.

Those are not identical conclusions.

Diabetic neuropathy develops through complex metabolic and vascular processes that can damage peripheral nerves over time. According to the American Diabetes Association, treatment for peripheral neuropathy focuses on slowing progression, relieving pain, managing complications, and protecting the feet.

Spinal cord stimulation works differently. An implanted system delivers electrical stimulation that alters pain-related signaling within the nervous system. The FDA has approved certain spinal cord stimulation systems for chronic pain associated with diabetic neuropathy.

Why sensory function improved in the SENZA-PDN trial remains an important research question. Neuromodulation may influence how sensory information is processed. However, improved clinical testing does not by itself demonstrate anatomical nerve regeneration.

Future studies incorporating objective measures of peripheral nerve structure and function could help clarify the mechanism. Until then, improved sensory function should be discussed as a promising clinical observation rather than evidence that peripheral nerve damage from diabetes has been reversed.

What These Findings Could Mean for Patient Care

For clinicians and patients, the most established benefit remains significant pain reduction in appropriately selected people with refractory painful diabetic neuropathy. The durability of that response is noteworthy.

Additional SENZA-PDN analyses have also reported improvements in diabetes-related quality of life, functioning, and treatment satisfaction. These outcomes suggest that effective pain control can have effects that reach well beyond a pain score.

The sensory findings add another dimension. Improved protective sensation could theoretically help patients recognize pressure or injury earlier. However, researchers still need to determine whether sensory improvements translate into fewer ulcers, infections, or amputations over longer follow-up periods.

Therefore, patients who experience better sensation after spinal cord stimulation should not assume their neuropathy has disappeared.

Daily foot inspection remains important. So do appropriate footwear, regular foot examinations, glucose management, and prompt evaluation of wounds or skin changes. People with diabetic neuropathy should continue preventive foot care even when pain or sensation improves.

Spinal cord stimulation also requires an implanted device and is not appropriate for everyone. Patient selection, treatment goals, procedural risks, and expected benefits should be reviewed with qualified clinicians experienced in diabetic neuropathy and neuromodulation.

Conclusion

Evidence surrounding spinal cord stimulation for painful diabetic neuropathy is beginning to challenge the idea that SCS affects pain alone. In the SENZA-PDN research, 10 kHz stimulation produced durable pain relief, while many participants also demonstrated neurological or sensory improvement.

Those results are clinically intriguing, particularly because loss of protective sensation contributes to serious diabetic foot complications.

However, improved sensation should not be described as proof that diabetic nerve damage has been reversed. Current evidence demonstrates functional changes, not confirmed peripheral nerve regeneration.

For now, spinal cord stimulation may offer a treatment option for selected patients with refractory painful diabetic neuropathy, with potential benefits that could extend beyond pain control. Further research should determine why sensation improves and, crucially, whether those changes lead to fewer long-term foot complications.

Frequently Asked Questions

Can spinal cord stimulation restore sensation in diabetic neuropathy?

Clinical research has found improved sensory and neurological assessments in some patients receiving 10 kHz spinal cord stimulation. However, this does not prove that damaged peripheral nerves have regenerated or that diabetic neuropathy has been reversed.

How effective is spinal cord stimulation for painful diabetic neuropathy?

In the 24-month SENZA-PDN results, mean pain reduction was 79.9%, and 90.1% of participants receiving 10 kHz SCS experienced at least 50% pain relief. Individual results can vary, and treatment requires careful patient selection.

What is protective sensation?

Protective sensation is the ability to detect pressure, pain, or other stimuli that warn a person about potential injury. Losing this ability can allow foot injuries to go unnoticed, increasing the risk of complications.

Does improved sensation mean patients can stop checking their feet?

No. People with diabetic neuropathy should continue regular foot examinations and daily foot checks even if symptoms or sensation improve. Better sensation does not establish that the underlying neuropathy has resolved.

Does spinal cord stimulation cure diabetic neuropathy?

No. Current evidence supports spinal cord stimulation as a treatment option for refractory painful diabetic neuropathy, but it has not been shown to cure the underlying neuropathy or definitively regenerate damaged peripheral nerves.

This content is not medical advice. For any health issues, always consult a healthcare professional. In an emergency, call 911 or your local emergency services.